These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4960087)

  • 1. Cytosine arabinoside sensitivity in actinobolin-resistant Streptococcus faecalis: the basis of a utilitarian microbiological assay.
    Pittillo RF; Hunt DE
    Proc Soc Exp Biol Med; 1967 Feb; 124(2):636-40. PubMed ID: 4960087
    [No Abstract]   [Full Text] [Related]  

  • 2. The gross and biochemical effects of 1- -D-arabinofuranosyl cytosine on an actinobolin-resistant strain of Streptococcus faecalis.
    Narkates AJ; Hunt DE
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):948-53. PubMed ID: 4632485
    [No Abstract]   [Full Text] [Related]  

  • 3. Microbiological assay for cytosine arabinoside (NSC-63878) in biologic materials containing other antitumor or antibacterial drugs.
    Hanka LJ
    Cancer Chemother Rep; 1971 Dec; 55(5):557-60. PubMed ID: 5003620
    [No Abstract]   [Full Text] [Related]  

  • 4. A microbiological assay for cyclocytidine--disposition studies in mice.
    Neil GL; Kuentzel SL; Berger AE
    Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):561-72. PubMed ID: 4633769
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of actinobolin on nucleic acid and protein synthesis in Streptococcus faecalis.
    Hunt DE; Narkates AJ
    J Dent Res; 1971; 50(6):1610-5. PubMed ID: 5002004
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.
    Neil GL; Moxley TE; Manak RC
    Cancer Res; 1970 Aug; 30(8):2166-72. PubMed ID: 4990003
    [No Abstract]   [Full Text] [Related]  

  • 7. [Crossed resistance to aminoglycoside antibiotics in Streptococcus faecalis].
    Soriano García F
    Rev Clin Esp; 1979 Nov; 155(3):215-8. PubMed ID: 120957
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility of enterococci. II. Inhibitory and bactericidal activity of drugs in combination against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):309-12. PubMed ID: 3098441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-resistant plasmids in clinically isolated Streptococcus faecalis].
    Natsuno T; Mikami M; Nakae M; Saito K
    Shigaku; 1986 Aug; 74(2):404-11. PubMed ID: 3099237
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of enterococci. I. Inhibitory and bactericidal activity of several chemoantibiotics against Streptococcus faecalis and Streptococcus faecium.
    Fabbri A; Manno G; Tacchella A; Belli ML; Palmero C
    Chemioterapia; 1986 Oct; 5(5):302-8. PubMed ID: 3098440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the oral administration of multiple-drug-resistant Streptococcus faecalis to normal individuals].
    Yoshida K; Hirooka S; Meguro T; Ozawa K
    Nihon Densenbyo Gakkai Zasshi; 1967 Feb; 40(11):377-80. PubMed ID: 4963104
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug resistance in Streptococcus faecalis, Streptococcus faecium and Staphylococcus epidermidis isolated from laboratory animals.
    Shimoda K; Maejima K; Urano T
    Jikken Dobutsu; 1984 Jul; 33(3):351-5. PubMed ID: 6437850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved microbiological assay for cytosine arabinoside (NSC-63878).
    Hanka LJ; Kuentzel SL; Neil GL
    Cancer Chemother Rep; 1970 Dec; 54(6):393-7. PubMed ID: 5003583
    [No Abstract]   [Full Text] [Related]  

  • 14. Microbiologic assay for cytosine arabinoside (NSC-63878): the use of a mutant of streptococcus faecium var. durans resistant to methotrexate (NSC-740) and 6-mercaptopurine (NSC-755).
    Mehta BM; Meyers MB; Hutchison DJ
    Cancer Chemother Rep; 1975; 59(3):515-22. PubMed ID: 1203881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Group D streptococci and enterococci: identification, sensitivity to antibiotics and a study of the high level resistance to aminosides (Charles Nicolle Hospital in Tunis)].
    Kechrid A; Ben Redjeb S; Gargouri J; Fendri C; Ben Hassen E; Boujnah A
    Med Trop (Mars); 1991; 51(2):177-80. PubMed ID: 1910140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterococcus faecalis resistance to drugs: recent trends and development of high-level resistance to aminoglycosides.
    Nicoletti G; Stefani S
    J Chemother; 1989 Aug; 1(4):219-22. PubMed ID: 2509642
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic resistance among enterococci: current problems and management strategies.
    Murray BE
    Curr Clin Top Infect Dis; 1991; 11():94-117. PubMed ID: 1907832
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance of clinical isolates of some Enterobacteriaceae as well as Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus faecalis to chemotherapeutic agents. Results of an inter-regional cooperative study for the years 1980 and 1981].
    Wiedemann B
    Infection; 1982; 10(5):310-4. PubMed ID: 6816738
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microbiological and chemotherapeutic study of the antibiotic mutabilicin].
    Perrova MA; Shneerson AN; Tebiakina AE; Navashin SM; Braginskaia PS
    Antibiotiki; 1967 May; 12(5):404-6. PubMed ID: 4385808
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of enterococci to antibiotic combinations.
    Chen HY
    J Antimicrob Chemother; 1986 Jul; 18(1):1-4. PubMed ID: 3093442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.